NCT01986270View on ClinicalTrials.gov

Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo

PHASE3CompletedINTERVENTIONAL
Enrollment

1,141

Participants

Timeline

Start Date

December 31, 1996

Primary Completion Date

January 31, 1998

Study Completion Date

January 31, 1998

Conditions
Migraine With or Without Aura
Interventions
DRUG

Placebo

Matching Placebo

DRUG

Eletriptan 40 mg

40mg oral

DRUG

Eletriptan 80 mg

80mg oral

DRUG

Sumatriptan 25 mg

25mg oral

DRUG

Sumatriptan 50 mg

50mg oral

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT01986270 - Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo | Biotech Hunter | Biotech Hunter